2017
DOI: 10.1007/s10565-017-9384-y
|View full text |Cite
|
Sign up to set email alerts
|

Clinical potentials of human pluripotent stem cells

Abstract: Aging, injuries, and diseases can be considered as the result of malfunctioning or damaged cells. Regenerative medicine aims to restore tissue homeostasis by repairing or replacing cells, tissues, or damaged organs, by linking and combining different disciplines including engineering, technology, biology, and medicine. To pursue these goals, the discipline is taking advantage of pluripotent stem cells (PSCs), a peculiar type of cell possessing the ability to differentiate into every cell type of the body. Huma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(33 citation statements)
references
References 80 publications
0
32
0
1
Order By: Relevance
“…Mesenchymal stem cells (MSCs) are classically defined as multipotent cells, which can differentiate into diverse cell types, including bone, cartilage, fat, tendon, muscle, and marrow stroma [54], and can be obtained from many sources, such as bone, tendon, skin, adipose tissue, umbilical cord, blood, and amnion [55]. In addition, MSCs are poorly immunogenic [56]. MSCs should be plastic adherent, have fibroblast-like morphology, express stromal markers CD73, CD90, and CD105, and be negative for the hematopoietic markers CD14, CD34, and CD45 [57].…”
Section: Neuronal Differentiation Of Mscsmentioning
confidence: 99%
“…Mesenchymal stem cells (MSCs) are classically defined as multipotent cells, which can differentiate into diverse cell types, including bone, cartilage, fat, tendon, muscle, and marrow stroma [54], and can be obtained from many sources, such as bone, tendon, skin, adipose tissue, umbilical cord, blood, and amnion [55]. In addition, MSCs are poorly immunogenic [56]. MSCs should be plastic adherent, have fibroblast-like morphology, express stromal markers CD73, CD90, and CD105, and be negative for the hematopoietic markers CD14, CD34, and CD45 [57].…”
Section: Neuronal Differentiation Of Mscsmentioning
confidence: 99%
“…Embryonic stem cells (ESCs) are pluripotent cells capable of unlimited self-renewal and differentiation into all three germ layers [1,2], making them an attractive source for the development of in vitro disease models and drug discovery as well as tissue engineering and cellular therapies [3][4][5]. These applications require stringent conditions for characterization and expansion as well as differentiation of cells into homogenous populations of progenitors or derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…This hiPSC-based, patient-centric approach opens up great possibilities for drug development, both in terms of the scope of illnesses approachable, including disorders caused by rare mutations, as well as improved safety by the early identification of drug side effects in human cells. Nevertheless, hiPSCs are also associated with a variety of scientific challenges that must be resolved to realize the full potential of the technology (see e.g., [4,6,7,8,9,10]).…”
Section: Introductionmentioning
confidence: 99%